NASDAQ:NXTM - NxStage Medical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $30.00 0.00 (0.00 %) (As of 02/21/2019)Previous Close$30.00Today's Range$29.98 - $30.0052-Week Range$23.17 - $30.00Volume2.61 million shsAverage Volume1.51 million shsMarket Capitalization$2.00 billionP/E RatioN/ADividend YieldN/ABeta0.25 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email NxStage Medical, Inc., a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. The company operates through three segments: System One, In-Center, and Services. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment, as well as sells disposable products in the home and critical care market for the treatment of end-stage renal disease (ESRD) patients in the home or a home-like setting and in the critical care market for the treatment of hospital-based patients with acute kidney failure or fluid overload. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers, and needles for apheresis. The Services segment offers dialysis services to patients at NxStage Kidney Care dialysis centers. As of February 3, 2018, it had 21 centers. NxStage Medical, Inc. markets its products through direct sales to dialysis clinics and hospitals in the United States, the United Kingdom, and Canada, as well as through distributors in Europe and internationally. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts. Receive NXTM News and Ratings via Email Sign-up to receive the latest news and ratings for NXTM and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:NXTM Previous Symbol CUSIP67072V10 CIK1333170 Webwww.nxstage.com Phone978-687-4700Debt Debt-to-Equity RatioN/A Current Ratio3.60 Quick Ratio2.69Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$393.94 million Price / Sales5.08 Cash Flow$0.2911 per share Price / Cash Flow103.07 Book Value$3.22 per share Price / Book9.32Profitability EPS (Most Recent Fiscal Year)($0.22) Net Income$-14,470,000.00 Net Margins-1.29% Return on Equity-2.50% Return on Assets-1.60%Miscellaneous EmployeesN/A Outstanding Shares66,680,000Market Cap$2.00 billion Next Earnings DateN/A OptionableOptionable NxStage Medical (NASDAQ:NXTM) Frequently Asked Questions What is NxStage Medical's stock symbol? NxStage Medical trades on the NASDAQ under the ticker symbol "NXTM." How were NxStage Medical's earnings last quarter? NxStage Medical, Inc. (NASDAQ:NXTM) released its quarterly earnings results on Monday, August, 7th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.00. The medical device company had revenue of $92.20 million for the quarter, compared to analyst estimates of $96.47 million. NxStage Medical had a negative net margin of 1.29% and a negative return on equity of 2.50%. NxStage Medical's revenue for the quarter was up .0% on a year-over-year basis. During the same quarter last year, the firm posted ($0.03) EPS. View NxStage Medical's Earnings History. Has NxStage Medical been receiving favorable news coverage? News stories about NXTM stock have been trending somewhat positive on Thursday, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. NxStage Medical earned a media sentiment score of 1.5 on InfoTrie's scale. They also assigned news headlines about the medical device company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. Who are some of NxStage Medical's key competitors? Some companies that are related to NxStage Medical include Masimo (MASI), GETINGE AB/ADR (GNGBY), LivaNova (LIVN), CONMED (CNMD), Natus Medical (BABY), AxoGen (AXGN), Viewray (VRAY), BioLife Solutions (BLFS), Semler Scientific (SMLR), Rockwell Medical (RMTI), Cutera (CUTR), electroCore (ECOR), Zynex (ZYXI), Edap Tms (EDAP) and BioSig Technologies (BSGM). What other stocks do shareholders of NxStage Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other NxStage Medical investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Hawkins (HWKN), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Och-Ziff Capital Management Group (OZM), Gran Tierra Energy (GTE) and ALJ Regional (ALJJ). Who are NxStage Medical's key executives? NxStage Medical's management team includes the folowing people: Mr. Jeffrey H. Burbank, Founder, CEO & Director (Age 56)Mr. Joseph E. Turk Jr., Pres (Age 51)Mr. Matthew W. Towse, Sr. VP, CFO & Treasurer (Age 56)Ms. Winifred L. Swan, Sr. VP, Gen. Counsel & Sec. (Age 55)Dr. Allan J. Collins, Head of Scientific Advisory Board & Chief Medical Officer How do I buy shares of NxStage Medical? Shares of NXTM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is NxStage Medical's stock price today? One share of NXTM stock can currently be purchased for approximately $30.00. How big of a company is NxStage Medical? NxStage Medical has a market capitalization of $2.00 billion and generates $393.94 million in revenue each year. The medical device company earns $-14,470,000.00 in net income (profit) each year or ($0.22) on an earnings per share basis. What is NxStage Medical's official website? The official website for NxStage Medical is http://www.nxstage.com. How can I contact NxStage Medical? NxStage Medical's mailing address is 350 MERRIMACK STREET, LAWRENCE MA, 01843. The medical device company can be reached via phone at 978-687-4700 or via email at [email protected] MarketBeat Community Rating for NxStage Medical (NASDAQ NXTM)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 335 (Vote Outperform)Underperform Votes: 281 (Vote Underperform)Total Votes: 616MarketBeat's community ratings are surveys of what our community members think about NxStage Medical and other stocks. Vote "Outperform" if you believe NXTM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NXTM will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/25/2019 by MarketBeat.com StaffFeatured Article: What is a Lock-Up Period?